Period:
Draw Mode:
| Volume | 181,946 |
|
|||||
| News | - | ||||||
| Day High | 54.82 | Low High |
|||||
| Day Low | 54.34 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Dr Reddys Laboratories Ltd | RDY | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.12 | 0.22% | 54.48 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 54.35 | 54.34 | 54.82 | 54.48 | 54.36 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,391 | 181,946 | $ 54.59 | $ 9,931,600 | - | 49.59 - 58.28 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:00:00 | 11,947 | $ 54.48 | USD |
Dr Reddys Laboratories Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 9.05B | 166.11M | 166.11M | $ 2.82B | $ 426.20M | 1.87 | 20.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 0.33 | 0.70% | 08/01/22 | - | - |
Dr Reddys Laboratories News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RDY Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 53.03 | 55.589 | 53.03 | 54.61 | 258,345 | 1.45 | 2.73% |
| 1 Month | 54.10 | 55.589 | 52.24 | 53.98 | 196,820 | 0.38 | 0.7% |
| 3 Months | 51.85 | 55.589 | 51.17 | 53.67 | 185,696 | 2.63 | 5.07% |
| 6 Months | 50.67 | 57.65 | 49.795 | 53.84 | 205,950 | 3.81 | 7.52% |
| 1 Year | 53.31 | 58.28 | 49.59 | 53.93 | 207,497 | 1.17 | 2.19% |
| 3 Years | 36.08 | 75.50 | 34.90 | 58.00 | 181,251 | 18.40 | 51.0% |
| 5 Years | 32.38 | 75.50 | 28.13 | 47.52 | 205,692 | 22.10 | 68.25% |
Dr Reddys Laboratories Description
| Headquartered in India, Dr. Reddy's Laboratories develops and manufactures generic pharmaceutical products sold across the world. The company specializes in low-cost, easy-to-produce small-molecule generic drugs and active pharmaceutical ingredients. Its drug portfolio in recent years has included biosimilar drug launches in select emerging markets and has shifted toward injectables and more complex generic products. Geographically, the company's sales are well dispersed across North America, India, and other emerging markets. |